Andrew S. Lee

Nottingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Spindle cell carcinoma of the breast resembling pseudoangiomatous stromal hyperplasia.

Spindle cell carcinoma of the breast resembling pseudoangiomatous stromal hyperplasia.

Journal: Journal of clinical pathology
Published: November 28, 2024

Retesting of oestrogen receptor, progesterone receptor and HER2 status of invasive carcinoma of the breast after neoadjuvant chemotherapy.

Retesting of oestrogen receptor, progesterone receptor and HER2 status of invasive carcinoma of the breast after neoadjuvant chemotherapy.

Journal: Histopathology
Published: September 02, 2024

Deciphering the Clinical Behaviour of Invasive Lobular Carcinoma of the Breast Defines an Aggressive Subtype.

Deciphering the Clinical Behaviour of Invasive Lobular Carcinoma of the Breast Defines an Aggressive Subtype.

Journal: Cancers
Published: May 07, 2024

HER2-positive grade 1 invasive carcinomas of the breast.

HER2-positive grade 1 invasive carcinomas of the breast.

Journal: Histopathology
Published: May 02, 2024

Revisiting surgical margins for invasive breast cancer patients treated with breast conservation therapy - Evidence for adopting a 1 mm negative width.

Revisiting surgical margins for invasive breast cancer patients treated with breast conservation therapy - Evidence for adopting a 1 mm negative width.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: April 24, 2024

Should a borderline negative HER2 result in a core biopsy of invasive carcinoma of the breast have HER2 assessment repeated in the excision specimen?

Should a borderline negative HER2 result in a core biopsy of invasive carcinoma of the breast have HER2 assessment repeated in the excision specimen?

Journal: Journal of clinical pathology
Published: July 25, 2023

Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland -on behalf of the UK national coordinating committee for breast pathology.

Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland -on behalf of the UK national coordinating committee for breast pathology.

Journal: Breast (Edinburgh, Scotland)
Published: April 26, 2023

Second opinion (external specialist referral) practice of breast pathology: the Nottingham experience.

Second opinion (external specialist referral) practice of breast pathology: the Nottingham experience.

Journal: Histopathology
Published: February 04, 2023

The Clinical and Biological Significance of Estrogen Receptor-Low Positive Breast Cancer.

The Clinical and Biological Significance of Estrogen Receptor-Low Positive Breast Cancer.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: February 04, 2023

Preoperative diagnosis of ductal carcinoma in situ of the breast over a 24-year period.

Preoperative diagnosis of ductal carcinoma in situ of the breast over a 24-year period.

Journal: Histopathology
Published: January 04, 2023

UK recommendations for HER2 assessment in breast cancer: an update.

UK recommendations for HER2 assessment in breast cancer: an update.

Journal: Journal of clinical pathology
Published: October 13, 2022

The frequency of HER2 amplification and the percentage of membrane staining in HER2 2 + invasive carcinomas of the breast.

The frequency of HER2 amplification and the percentage of membrane staining in HER2 2 + invasive carcinomas of the breast.

Journal: Virchows Archiv : an international journal of pathology
Published: April 10, 2022
Showing 1-12 of 56

Last Updated: 09/26/2026